Literature DB >> 11275473

Spin trapping agents (Tempol and POBN) protect HepG2 cells overexpressing CYP2E1 against arachidonic acid toxicity.

M J Pérez1, A I Cederbaum.   

Abstract

Polyunsaturated fatty acids such as arachidonic acid were previously shown to be toxic to HepG2 cells expressing CYP2E1 by a mechanism involving oxidative stress and lipid peroxidation. This study investigated the effects of the spin trapping agents Tempol and POBN on the arachidonic acid toxicity. Arachidonic acid caused toxicity and induced lipid peroxidation and mitochondrial membrane damage in cells overexpressing CYP2E1 but had little or no effect in control cells not expressing CYP2E1. The toxicity appeared to be both apoptotic and necrotic in nature. 4-Hydroxy-[2,2,6,6-tetramethylpiperidine-1-oxyl] (Tempol) and alpha-(4-pyridyl-1-oxide)-N-tert-butyl nitrone (POBN) protected against the decrease in cell viability and the apoptosis and necrosis. These spin traps prevented the enhanced lipid peroxidation and the loss of mitochondrial membrane potential. Tempol and POBN had little or no effect on cellular viability or on CYP2E1 activity at concentrations which were protective. It is proposed that elevated production of reactive oxygen intermediates by cells expressing CYP2E1 can cause lipid peroxidation, which subsequently damages the mitochondrial membrane leading to a loss in cell viability when the cells are enriched with arachidonic acid. Tempol and POBN, which scavenge various radical intermediates, prevent in this way the enhanced lipid peroxidation, mitochondrial dysfunction, and the cell toxicity. Since oxidative stress appears to play a key role in ethanol hepatotoxicity, it may be of interest to evaluate whether such spin trapping agents are useful candidates for the prevention or improvement of ethanol-induced liver injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275473     DOI: 10.1016/s0891-5849(01)00461-0

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

1.  Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect.

Authors:  Liqun Huang; Caihua Zhu; Yu Sun; Gang Xie; Gerardo G Mackenzie; George Qiao; Despina Komninou; Basil Rigas
Journal:  Carcinogenesis       Date:  2010-07-12       Impact factor: 4.944

2.  Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells.

Authors:  M J Perez; E Gonzalez-Sanchez; A Gonzalez-Loyola; J M Gonzalez-Buitrago; J J G Marin
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  In vitro neuroprotection against oxidative stress by pre-treatment with a combination of dihydrolipoic acid and phenyl-butyl nitrones.

Authors:  Michael L Koenig; James L Meyerhoff
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

4.  TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction.

Authors:  Nithya Mariappan; Carrie M Elks; Bruno Fink; Joseph Francis
Journal:  Free Radic Biol Med       Date:  2008-11-12       Impact factor: 7.376

5.  Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells.

Authors:  Xiaoqing Guo; Ji-Eun Seo; Steven M Bryce; Jenna A Tan; Qiangen Wu; Stacey L Dial; Martha M Moore; Nan Mei
Journal:  Toxicol Sci       Date:  2018-05-01       Impact factor: 4.849

6.  An in vitro screening cascade to identify neuroprotective antioxidants in ALS.

Authors:  Siân C Barber; Adrian Higginbottom; Richard J Mead; Stuart Barber; Pamela J Shaw
Journal:  Free Radic Biol Med       Date:  2009-01-30       Impact factor: 7.376

7.  Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1.

Authors:  A Holownia; R M Mroz; P Wielgat; P Jakubow; J Jablonski; J Sulek; J J Braszko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-28       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.